[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TohJah7809 Avatar @TohJah7809 TohJah

TohJah posts on X about $zlab, $twst, $nvo, $lly the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% technology brands XXXX% cryptocurrencies XXXX% social networks XXXX% countries XXXX%

Social topic influence $zlab #2, $twst 11.54%, $nvo #81, $lly #60, $arkg #1, $jd 3.85%, baidu 3.85%, alibaba 3.85%, tencent 3.85%, $9888hk XXXX%

Top accounts mentioned or mentioned by @biotechfq @finseemain @dadbod4evah

Top assets mentioned Twist Bioscience Corporation Common Stock (TWST) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Vertex Protocol (VRTX) Viking Therapeutics, Inc (VKTX) Pfizer, Inc. (PFE) Adaptive Biotechnologies Corporation Common Stock (ADPT) Bitcoin Incognito (XBI) Merck & Co., Inc. (MRK) AbbVie Inc (ABBV) Bristol-Myers Squibb Co (BMY) Synthetify (SNY) Johnson & Johnson (JNJ) Gilead Sciences, Inc. (GILD)

Top Social Posts

Top posts by engagements in the last XX hours

"Credit research on $JD 9618 HK Cheaper than BAT (Baidu Alibaba Tencent)"
X Link 2024-03-09T10:08Z 2102 followers, XXX engagements

"$VRTX $ZLAB Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-11-16T16:19Z 2102 followers, XXX engagements

"$RLAY Q3 results: p3 doublet breast cancer trial ongoing p1/2 triplet trial ongoing p1/2 vascular malformations trial ongoing $596m cash runway to 2029 😵 Stock been rallying quietly the past X months 2x (despite lack of any catalysts) - used to trade under cash 🔺📈💹 Will there be any data updates in SABCS next month 🤔🗓 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-11-22T08:25Z 2102 followers, 3930 engagements

"$TWST Twist Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-12-06T08:39Z 2101 followers, XXX engagements

"$TWST Canadian indie fund EdgePoint owns XXXX% of Twist as of Sep XX 2025 👇👀 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-11-16T15:57Z 2101 followers, 4836 engagements

"$TWST full-year results: I like @Finsee_main summary 👇👀 Growth is slower than expected in NGS segment driven by a large customer transition (will hit this quarter again 😱) which is expected to reverse early next year Next quarter: new revenue reporting by industry (see tweet 👇) Market is unhappy with this slower growth: stock -XX% this week I think we'll need to be patient w/ Twist hold"
X Link 2025-11-16T16:07Z 2101 followers, XXX engagements

"$RLAY's top🔟shareholders: Strange mix of generalists and healthcare funds 🥇 SoftBank # 1🤨 Point72/ SAC is another generalist🤔(this PM had been holding for some time and been averaging down) Healthcare funds: Commodore Casdin Bellevue Tang Nextech half of top🔟owners"
X Link 2025-11-22T08:25Z 2101 followers, XXX engagements

"GLP-1-based therapies $LLY $NVO $VKTX $PFE 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-12-11T10:01Z 2101 followers, XXX engagements

"$ZLAB Zai Lab Announces Updated Phase X Data for Zocilurtatug Pelitecan (formerly ZL-1310) Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer and Initiation of Global Phase X Registrational Study Updated p1 data for DLL-3 ADC for lung cancer 🫁 Good safety decent efficacy ✅ P3 initiated for 2L 1L will be initiated in 2026 👍 Comparison of this Oct (AACR) update vs Jun data 👇👀 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-11-08T16:00Z 2101 followers, XXX engagements

"Ark's weekly bio commentaries: $ARKG $ADPT 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-12-06T08:41Z 2101 followers, XXX engagements

"$ZLAB Q3 earnings: Double miss + lower guidance 🤦♀🤦♂ 2025 revenue now = $460m (vs $560m-$590m previously) Q3 sales growth only XX% No longer "on track to achieve adjusted profitability in 2025 Q4" - I guess they'll achieve it in 2026 Share price crushed -XX% this week 🔻📉🔥 $817m cash trading at $2.65b - this is a cheap stock (China discount) 🤷♂ I'm long and will add in coming months Busy pipeline 👇👀 and they move fast ❗ 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-11-08T16:17Z 2101 followers, XXX engagements

"News release:"
X Link 2025-11-08T16:17Z 2101 followers, XXX engagements

"2026 top selling drugs forecast $XLV $XBI $ARKG $MRK $LLY $ABBV $SNY $NVO $JNJ $GILD $BMY 🥼🔬🧫🧪🦠🧬💻🧑🔬🤒🌡💉🩸🩹💊😷🩺🏥⚕"
X Link 2025-12-11T10:03Z 2102 followers, XXX engagements